Viewing Study NCT00124735


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2025-12-25 @ 7:45 PM
Study NCT ID: NCT00124735
Status: COMPLETED
Last Update Posted: 2016-08-24
First Post: 2005-07-26
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Determine the Dose Requirements of Rocuronium Bromide (ZemuronĀ®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-10
Start Date Type: None
Primary Completion Date: 2007-08
Primary Completion Date Type: ACTUAL
Completion Date: 2007-09
Completion Date Type: ACTUAL
First Submit Date: 2005-07-26
First Submit QC Date: None
Study First Post Date: 2005-07-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2008-12-05
Results First Submit QC Date: None
Results First Post Date: 2009-04-15
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-07-14
Last Update Post Date: 2016-08-24
Last Update Post Date Type: ESTIMATED